Coral Laboratories Ltd. - Research Center
524506 CORALAB Group (X) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
| 197.63 |
173.92 |
151.23 |
152.48 |
133.07 |
Secured loans
Unsecured loans
Total
| 204.76 |
177.50 |
154.80 |
162.09 |
142.90 |
Gross block
| 51.25 |
50.91 |
50.16 |
46.53 |
42.15 |
Less : revaluation reserve
Less : accumulated depreciation
| 28.52 |
26.63 |
24.90 |
22.75 |
20.71 |
Net block
| 22.73 |
24.28 |
25.26 |
23.78 |
21.44 |
Capital work-in-progress
Investments
| 52.34 |
49.75 |
41.29 |
46.18 |
33.18 |
Current assets, loans & advances
| 151.91 |
131.65 |
107.79 |
118.21 |
112.42 |
Less : current liabilities & provisions
| 24.70 |
28.18 |
19.55 |
27.80 |
24.64 |
Total net current assets
| 127.21 |
103.47 |
88.25 |
90.41 |
87.78 |
Miscellaneous expenses not written
Total
| 204.76 |
177.50 |
154.80 |
162.09 |
142.90 |
Book value of unquoted investments
Market value of quoted investments
| 52.34 |
49.75 |
23.88 |
24.43 |
33.18 |
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 35.73 |
35.73 |
35.73 |
35.73 |
35.73 |